Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LOS ANGELES, May 14, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, today announced its consolidated financial results and business progress for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
